| News
Botanikind settles in Basel
14.09.2021
The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for food and drink production.

Botanikind is pooling its European activities in its newly established headquarters in Basel. Botanikind AG was founded for this purpose will additionally coordinate global commercial activities and develop new innovations from its location in Basel. Botanikind was supported in settling by Basel Area Business & Innovation.
Botanikind has its operating headquarters in Shanghai and has established a vertically integrated supply chain in China. This means natural ingredients can be obtained directly from farmers for the food, drink and supplement industries. In doing so the company ensures quality and transparency between producers and consumers. The direct, simple supply chain additionally lowers costs. In China, the company sources from a broad range of natural raw materials and benefits from modern technologies.
Botanikind is proactively pursuing a decentralized structure in order to be as close to its customers as possible. The company sees Basel as the ideal location for its European headquarters as it is situated centrally and has great innovation potential due to the life sciences companies that are resident there. A team will now be established in Basel to make and implement strategic decisions for the European market. Furthermore, the company plans to open its own laboratory in Basel in the coming year. The proximity to life sciences companies is additionally important to Botanikind because the products it markets can also be used in supplements with health benefits.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
BeiGene opens European headquarters in Basel
BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...
Read MoreThe 25 Best AI Courses in the Basel Area, Germany and France
Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...
Read MoreEngimmune Therapeutics banks 15.5 million Swiss francs
Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...
Read MoreBionter receives 3 million US dollars in investments
Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...
Read MoreResistell seeking to further develop test to combat antibiotic resistance
The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...
Read MoreBiotech startup Cimeio receives 46 million Swiss francs for cell therapy
Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...
Read More